BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 8137258)

  • 1. Physiologically based pharmacokinetic model for specific and nonspecific monoclonal antibodies and fragments in normal tissues and human tumor xenografts in nude mice.
    Baxter LT; Zhu H; Mackensen DG; Jain RK
    Cancer Res; 1994 Mar; 54(6):1517-28. PubMed ID: 8137258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microautoradiographic analysis of the normal organ distribution of radioiodinated single-chain Fv and other immunoglobulin forms.
    Yokota T; Milenic DE; Whitlow M; Wood JF; Hubert SL; Schlom J
    Cancer Res; 1993 Aug; 53(16):3776-83. PubMed ID: 8339291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of biodistribution of 791T/36 monoclonal antibody and its Fab/c fragment in BALB/c mice and nude mice bearing human tumor xenografts.
    Demignot S; Pimm MV; Baldwin RW
    Cancer Res; 1990 May; 50(10):2936-42. PubMed ID: 2334894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of monoclonal immunoglobulin G1, F(ab')2, and Fab' in mice.
    Covell DG; Barbet J; Holton OD; Black CD; Parker RJ; Weinstein JN
    Cancer Res; 1986 Aug; 46(8):3969-78. PubMed ID: 3731067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of radiolabeled stabilized F(ab')2 fragments of monoclonal antiferritin in nude mouse model.
    Quadri SM; Lai J; Mohammadpour H; Vriesendorp HM; Williams JR
    J Nucl Med; 1993 Dec; 34(12):2152-9. PubMed ID: 8254403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative pharmacokinetics of a murine monoclonal antibody to a rat colon tumor in rats and nude mice.
    Laborda J; Douillard JY; Lizzio EF; Hoffman T
    Cancer Res; 1990 Feb; 50(3 Suppl):873s-876s. PubMed ID: 2297736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic studies of mouse monoclonal antibodies to a rat colon carcinoma: I. Comparison of biodistribution in normal rats, syngeneic tumor-bearing rats, or tumor-bearing nude mice.
    Laborda J; Douillard JY; Burg C; Lizzio EF; Ridge J; Levenbook I; Hoffman T
    J Nucl Med; 1990 Jun; 31(6):1028-34. PubMed ID: 2348232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A quantitative analysis of tumor specific monoclonal antibody uptake by human melanoma xenografts: effects of antibody immunological properties and tumor antigen expression levels.
    Shockley TR; Lin K; Sung C; Nagy JA; Tompkins RG; Dedrick RL; Dvorak HF; Yarmush ML
    Cancer Res; 1992 Jan; 52(2):357-66. PubMed ID: 1728407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
    Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing bispecific antibody pretargeting for use in radioimmunotherapy.
    Sharkey RM; Karacay H; Richel H; McBride WJ; Rossi EA; Chang K; Yeldell D; Griffiths GL; Hansen HJ; Goldenberg DM
    Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3897S-913S. PubMed ID: 14506188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic analysis of immunotoxin uptake in solid tumors: role of plasma kinetics, capillary permeability, and binding.
    Sung C; Youle RJ; Dedrick RL
    Cancer Res; 1990 Nov; 50(22):7382-92. PubMed ID: 2224866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical studies on the pharmacokinetic properties of human monoclonal antibodies to colorectal cancer and their use for detection of tumors.
    McCabe RP; Peters LC; Haspel MV; Pomato N; Carrasquillo JA; Hanna MG
    Cancer Res; 1988 Aug; 48(15):4348-53. PubMed ID: 3390831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An analysis of monoclonal antibody distribution in microscopic tumor nodules: consequences of a "binding site barrier".
    van Osdol W; Fujimori K; Weinstein JN
    Cancer Res; 1991 Sep; 51(18):4776-84. PubMed ID: 1893370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of syngeneic (anti-idiotypic) antibody responses on biodistribution and tumour localisation of murine monoclonal antibodies and fragments.
    Pimm MV; Gribben SJ
    Anticancer Res; 1993; 13(1):241-8. PubMed ID: 8476219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicted and observed effects of antibody affinity and antigen density on monoclonal antibody uptake in solid tumors.
    Sung C; Shockley TR; Morrison PF; Dvorak HF; Yarmush ML; Dedrick RL
    Cancer Res; 1992 Jan; 52(2):377-84. PubMed ID: 1728409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodistribution properties of (111)indium-labeled C-functionalized trans-cyclohexyl diethylenetriaminepentaacetic acid humanized 3S193 diabody and F(ab')(2) constructs in a breast carcinoma xenograft model.
    Tahtis K; Lee FT; Smyth FE; Power BE; Renner C; Brechbiel MW; Old LJ; Hudson PJ; Scott AM
    Clin Cancer Res; 2001 Apr; 7(4):1061-72. PubMed ID: 11309358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of monoclonal antibody uptake in human colon tumor xenografts following irradiation.
    Kalofonos H; Rowlinson G; Epenetos AA
    Cancer Res; 1990 Jan; 50(1):159-63. PubMed ID: 2403414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo targeting of malignant melanoma by 125Iodine- and 99mTechnetium-labeled single-chain Fv fragments against high molecular weight melanoma-associated antigen.
    Kang N; Hamilton S; Odili J; Wilson G; Kupsch J
    Clin Cancer Res; 2000 Dec; 6(12):4921-31. PubMed ID: 11156253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of daunomycin-antibody immunoconjugates in managing soft tissue sarcomas: nude mouse xenograft model.
    Stastny JJ; Das Gupta TK
    Cancer Res; 1993 Dec; 53(23):5740-4. PubMed ID: 8242630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of domain deletion, glycosylation, and long IgG3 hinge on the biodistribution and serum stability properties of a humanized IgG1 immunoglobulin, hLL2, and its fragments.
    Leung SO; Qu Z; Hansen HJ; Shih LB; Wang J; Losman MJ; Goldenberg DM; Sharkey RM
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3106s-3117s. PubMed ID: 10541351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.